Phase I Dose-Finding Study of E7070 [indisulam] in Combination With Irinotecan.
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2013
At a glance
- Drugs Indisulam (Primary) ; Irinotecan
- Indications Gastrointestinal cancer; Pancreatic cancer; Small cell lung cancer
- Focus Adverse reactions
- 04 Apr 2012 Planned end date changed from 1 Dec 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 08 Mar 2012 Planned end date changed from 1 Jul 2009 to 1 Dec 2012 as reported by ClinicalTrials.gov
- 08 May 2008 The expected completion date for this trial is now 1 July 2009, from clinicaltrials.gov record.